Breast cancer carries a BM risk of 0.4–9.2%, with most of the cases occurring in Human Epidermal Growth Factor Receptor 2 (HER2)-positive or triple-negative patients [26,27]. The gene discussed is ERBB2; the disease is breast cancer.